Artal Group as of March 31, 2016
Portfolio Holdings for Artal Group
Artal Group holds 50 positions in its portfolio as reported in the March 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Blue Buffalo Pet Prods | 57.6 | $3.0B | 115M | 25.66 | |
Lexicon Pharmaceuticals (LXRX) | 13.4 | $687M | 58M | 11.95 | |
Weight Watchers International | 8.3 | $428M | 29M | 14.53 | |
Goldman Sachs (GS) | 3.7 | $188M | 1.2M | 156.98 | |
Biogen Idec (BIIB) | 2.0 | $104M | 400k | 260.32 | |
Bank of America Corporation (BAC) | 1.4 | $74M | 5.5M | 13.52 | |
Celgene Corporation | 1.3 | $66M | 660k | 100.09 | |
Alnylam Pharmaceuticals (ALNY) | 0.9 | $47M | 750k | 62.77 | |
Incyte Corporation (INCY) | 0.8 | $44M | 600k | 72.47 | |
Apple (AAPL) | 0.8 | $44M | 400k | 108.99 | |
MetLife (MET) | 0.8 | $43M | 985k | 43.94 | |
Wal-Mart Stores (WMT) | 0.7 | $34M | 500k | 68.49 | |
BioMarin Pharmaceutical (BMRN) | 0.6 | $33M | 400k | 82.48 | |
Citigroup (C) | 0.6 | $31M | 750k | 41.75 | |
Alibaba Group Holding (BABA) | 0.6 | $30M | 375k | 79.03 | |
Nektar Therapeutics (NKTR) | 0.5 | $28M | 2.0M | 13.75 | |
JPMorgan Chase & Co. (JPM) | 0.5 | $27M | 450k | 59.22 | |
Teva Pharmaceutical Industries (TEVA) | 0.5 | $24M | 450k | 53.51 | |
Kite Pharma | 0.4 | $22M | 485k | 45.91 | |
Agios Pharmaceuticals (AGIO) | 0.4 | $22M | 535k | 40.60 | |
Bluebird Bio (BLUE) | 0.4 | $21M | 500k | 42.50 | |
Delphi Automotive | 0.4 | $21M | 275k | 75.02 | |
MasterCard Incorporated (MA) | 0.4 | $19M | 200k | 94.50 | |
Ionis Pharmaceuticals (IONS) | 0.3 | $14M | 350k | 40.50 | |
Juno Therapeutics | 0.3 | $14M | 365k | 38.09 | |
Morgan Stanley (MS) | 0.2 | $13M | 500k | 25.01 | |
Regeneron Pharmaceuticals (REGN) | 0.2 | $11M | 30k | 360.43 | |
Array BioPharma | 0.2 | $11M | 3.7M | 2.95 | |
Delta Air Lines (DAL) | 0.2 | $9.7M | 200k | 48.68 | |
Lendingclub | 0.2 | $9.3M | 1.1M | 8.30 | |
Seres Therapeutics (MCRB) | 0.1 | $6.0M | 225k | 26.56 | |
Cellectis S A (CLLS) | 0.1 | $5.8M | 210k | 27.50 | |
Spectranetics Corporation | 0.1 | $5.1M | 350k | 14.52 | |
Agenus (AGEN) | 0.1 | $5.2M | 1.3M | 4.16 | |
Avexis | 0.1 | $4.8M | 175k | 27.24 | |
Sarepta Therapeutics (SRPT) | 0.1 | $3.9M | 200k | 19.52 | |
BioTime | 0.1 | $3.7M | 1.3M | 2.87 | |
Ignyta | 0.1 | $3.4M | 500k | 6.77 | |
Palo Alto Networks (PANW) | 0.1 | $3.3M | 20k | 163.15 | |
Celldex Therapeutics | 0.1 | $2.6M | 675k | 3.78 | |
Ironwood Pharmaceuticals (IRWD) | 0.1 | $2.4M | 217k | 10.94 | |
Chemocentryx | 0.0 | $2.2M | 900k | 2.49 | |
Gaming & Leisure Pptys (GLPI) | 0.0 | $2.1M | 70k | 30.00 | |
Nantkwest | 0.0 | $1.8M | 225k | 8.22 | |
Dimension Therapeutics | 0.0 | $2.2M | 275k | 7.83 | |
Regenxbio Inc equity us cm (RGNX) | 0.0 | $1.7M | 160k | 10.80 | |
Parnell Pharmaceuticals Holdin (PARNF) | 0.0 | $1.1M | 500k | 2.13 | |
Oncocyte | 0.0 | $296k | 64k | 4.62 | |
Ceres | 0.0 | $225k | 1.0M | 0.22 | |
Colucid Pharmaceuticals | 0.0 | $35k | 5.6k | 6.28 |